Literature DB >> 28481424

Evaluating hepatocellular carcinoma cell lines for tumour samples using within-sample relative expression orderings of genes.

Lu Ao1, You Guo1,2, Xuekun Song3, Qingzhou Guan1, Weicheng Zheng1, Jiahui Zhang1, Haiyan Huang1, Yi Zou4, Zheng Guo1,5, Xianlong Wang1.   

Abstract

BACKGROUND & AIMS: Concerns are raised about the representativeness of cell lines for tumours due to the culture environment and misidentification. Liver is a major metastatic destination of many cancers, which might further confuse the origin of hepatocellular carcinoma cell lines. Therefore, it is of crucial importance to understand how well they can represent hepatocellular carcinoma.
METHODS: The HCC-specific gene pairs with highly stable relative expression orderings in more than 99% of hepatocellular carcinoma but with reversed relative expression orderings in at least 99% of one of the six types of cancer, colorectal carcinoma, breast carcinoma, non-small-cell lung cancer, gastric carcinoma, pancreatic carcinoma and ovarian carcinoma, were identified.
RESULTS: With the simple majority rule, the HCC-specific relative expression orderings from comparisons with colorectal carcinoma and breast carcinoma could exactly discriminate primary hepatocellular carcinoma samples from both primary colorectal carcinoma and breast carcinoma samples. Especially, they correctly classified more than 90% of liver metastatic samples from colorectal carcinoma and breast carcinoma to their original tumours. Finally, using these HCC-specific relative expression orderings from comparisons with six cancer types, we identified eight of 24 hepatocellular carcinoma cell lines in the Cancer Cell Line Encyclopedia (Huh-7, Huh-1, HepG2, Hep3B, JHH-5, JHH-7, C3A and Alexander cells) that are highly representative of hepatocellular carcinoma. Evaluated with a REOs-based prognostic signature for hepatocellular carcinoma, all these eight cell lines showed the same metastatic properties of the high-risk metastatic hepatocellular carcinoma tissues.
CONCLUSIONS: Caution should be taken for using hepatocellular carcinoma cell lines. Our results should be helpful to select proper hepatocellular carcinoma cell lines for biological experiments.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cell lines; hepatocellular carcinoma; relative expression orderings; tumour model

Mesh:

Year:  2017        PMID: 28481424     DOI: 10.1111/liv.13467

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  9 in total

1.  Comparison of Proteomics Profiles Between Xenografts Derived from Cell Lines and Primary Tumors of Thyroid Carcinoma.

Authors:  Luo Fang; Yu-Jia Liu; Yi-Wen Zhang; Zong-Fu Pan; Li-Ke Zhong; Lie-Hao Jiang; Jia-Feng Wang; Xiao-Wei Zheng; Ling-Ya Chen; Ping Huang; Ming-Hua Ge; Zhuo Tan
Journal:  J Cancer       Date:  2021-01-31       Impact factor: 4.207

2.  The phytochemical p-hydroxycinnamic acid suppresses the growth and stimulates the death in human liver cancer HepG2 cells.

Authors:  Masayoshi Yamaguchi; Tomiyasu Murata; Joe W Ramos
Journal:  Anticancer Drugs       Date:  2021-06-01       Impact factor: 2.389

3.  Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma.

Authors:  Dezhi Li; Xianyi Cheng; Wei Zheng; Junhui Chen
Journal:  Cancer Manag Res       Date:  2020-06-24       Impact factor: 3.989

4.  Qualitative transcriptional signatures for evaluating the maturity degree of pluripotent stem cell-derived cardiomyocytes.

Authors:  Rou Chen; Jun He; Yumei Wang; You Guo; Juan Zhang; Luying Peng; Duo Wang; Qin Lin; Jie Zhang; Zheng Guo; Li Li
Journal:  Stem Cell Res Ther       Date:  2019-03-29       Impact factor: 6.832

5.  Inhibition of Glyoxalase-I Leads to Reduced Proliferation, Migration and Colony Formation, and Enhanced Susceptibility to Sorafenib in Hepatocellular Carcinoma.

Authors:  Maurice Michel; Marcus Hollenbach; Sabine Pohl; Cristina Ripoll; Alexander Zipprich
Journal:  Front Oncol       Date:  2019-08-20       Impact factor: 6.244

6.  Distinguishing Kawasaki Disease from Febrile Infectious Disease Using Gene Pair Signatures.

Authors:  Jiayong Zhong; Qingsheng Huang; Yanfei Wang; Huan Gao; Hongling Jia; Jun Fan; Huiying Liang
Journal:  Biomed Res Int       Date:  2020-04-26       Impact factor: 3.411

7.  StemSC: a cross-dataset human stemness index for single-cell samples.

Authors:  Hailong Zheng; Jiajing Xie; Kai Song; Jing Yang; Huiting Xiao; Jiashuai Zhang; Keru Li; Rongqiang Yuan; Yuting Zhao; Yunyan Gu; Wenyuan Zhao
Journal:  Stem Cell Res Ther       Date:  2022-03-21       Impact factor: 6.832

Review 8.  The Influence of Chronic Liver Diseases on Hepatic Vasculature: A Liver-on-a-chip Review.

Authors:  Alican Özkan; Danielle Stolley; Erik N K Cressman; Matthew McMillin; Sharon DeMorrow; Thomas E Yankeelov; Marissa Nichole Rylander
Journal:  Micromachines (Basel)       Date:  2020-05-09       Impact factor: 2.891

9.  A novel RNA sequencing-based miRNA signature predicts with recurrence and outcome of hepatocellular carcinoma.

Authors:  Fumao Bai; Huaibin Zhou; Mengni Ma; Chen Guan; Jianxin Lyu; Qing H Meng
Journal:  Mol Oncol       Date:  2018-05-21       Impact factor: 6.603

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.